EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudieKohortenstudieOpen Access · CC BY 4.0

Unilateral biportal endoscopic lumbar interbody fusion versus minimally invasive transforaminal lumbar interbody fusion in the treatment of lumbar degenerative diseases: a retrospective multicenter cohort study

Xiang Chen, Jingbo Xie, Zhihui Zhang, Yi Liu, Liang Shi, Lang Hu iD

PLOS One · 26.09.2025 · 20 (9) · e0333165

DOI: 10.1371/journal.pone.0333165 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift PLOS One, online erschienen am 26.09.2025. Verfasst von Xiang Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Spinal Orthopaedics, Fengcheng People's Hospital, Fengcheng City, Jiangxi Province, China. Hauptthemen laut MEDLINE: Spinal Fusion, Lumbar Vertebrae, Minimally Invasive Surgical Procedures, Endoscopy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Minimally invasive transforaminal lumbar interbody fusion (Mis-TLIF) is one of the most commonly used methods for lumbar fusion. However, in recent years, the unilateral biportal endoscopic lumbar interbody fusion (UBE-LIF) has also gradually attracted the attention of spine surgeons. This study aims to compare the perioperative and long-term clinical outcomes of the two procedures for lumbar degenerative diseases (LDD).

Methods

We collected clinical data of patients who had undergone minimally invasive transforaminal lumbar interbody fusion (Mis-TLIF) or unilateral biportal endoscopic lumbar interbody fusion (UBE-LIF) for lumbar degenerative diseases (LDD) from January 2019 to December 2022. The primary outcome measure was the Oswestry Disability Index (ODI) at 12 months postoperatively. Secondary outcome measures included 12-month visual analog scale (VAS) scores for low back pain (LBP) and leg pain (LP), and postoperative complication rate.

Results

There were no significant differences in the preoperative VAS scores for LBP, LP, or ODI between the two groups. The VAS score for LBP was significantly lower in the UBE-LIF group than in the Mis-TLIF group 1 week postoperatively (1.4 ± 1.1 vs. 2.1 ± 1.0, P = 0.001). However, there was no significant difference in the VAS scores for LBP, LP, and ODI at 1, 6, and 12 months postoperatively. The length of stay was significantly lower in the UBE-LIF than in the Mis-TLIF group (5.2 ± 1.1 vs. 6.3 ± 1.2 days, P < 0.001). The operative time (188.9 ± 19.8 vs. 159.5 ± 11.6 minutes, P < 0.001) of the UBE-LIF group was significantly higher than that of the Mis-TLIF group, while the estimated blood loss (131.0 ± 21.9 vs. 191.7 ± 23.3 ml, P < 0.001) and postoperative drainage volume (123.0 ± 55.4 vs. 191.2 ± 47.5 ml, P < 0.001) were significantly lower in the UBE-LIF than in the Mis-TLIF group. The complication rate was slightly higher in the UBE-LIF than in the Mis-TLIF group; however, the difference was not significant (11.5% vs. 5.0%, P = 0.299).

Conclusion

UBE-LIF can achieve better perioperative clinical outcomes than Mis-TLIF. However, in the long-term, these two procedures can achieve equivalent clinical efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spinal FusionLumbar VertebraeMinimally Invasive Surgical ProceduresEndoscopyIntervertebral Disc DegenerationHumansFemaleMaleMiddle AgedRetrospective StudiesAgedTreatment OutcomePostoperative ComplicationsLow Back Pain

Autor:innen und Institutionen

  • Department of Spinal Orthopaedics, Fengcheng People's Hospital, Fengcheng City, Jiangxi Province, China.
  • Department of Orthopedics, Xiangyang No.1 People's Hospital, Hubei University of Medicine, Xiangyang City, Hubei Province, China.

ORCID-Profile: Lang Hu

Zitieren

APA

Chen, X., Xie, J., Zhang, Z., Liu, Y., Shi, L., & Hu, L. (2025). Unilateral biportal endoscopic lumbar interbody fusion versus minimally invasive transforaminal lumbar interbody fusion in the treatment of lumbar degenerative diseases: a retrospective multicenter cohort study. PLOS One, 20(9), e0333165. https://doi.org/10.1371/journal.pone.0333165

Vancouver

Chen X, Xie J, Zhang Z, Liu Y, Shi L, Hu L. Unilateral biportal endoscopic lumbar interbody fusion versus minimally invasive transforaminal lumbar interbody fusion in the treatment of lumbar degenerative diseases: a retrospective multicenter cohort study. PLOS One. 2025;20(9):e0333165. doi:10.1371/journal.pone.0333165

BibTeX
@article{Chen2025,
  author = {Chen, Xiang and Xie, Jingbo and Zhang, Zhihui and Liu, Yi and Shi, Liang and Hu, Lang},
  title = {Unilateral biportal endoscopic lumbar interbody fusion versus minimally invasive transforaminal lumbar interbody fusion in the treatment of lumbar degenerative diseases: a retrospective multicenter cohort study},
  journal = {PLOS One},
  year = {2025},
  volume = {20},
  number = {9},
  pages = {e0333165},
  doi = {10.1371/journal.pone.0333165}
}
Kostenlos starten →